Safety and Drug Interaction of Cassia auriculata
Author Information
Author(s): Puranik Amrutesh S., Halade Ganesh, Kumar Sandeep, Mogre Ranjan, Apte Kishori, Vaidya Ashok D. B., Patwardhan Bhushan
Primary Institution: Interdisciplinary School of Health Sciences, University of Pune
Hypothesis
The study investigates the safety and pharmacokinetic interactions of Cassia auriculata extracts with metformin.
Conclusion
Both extracts of Cassia auriculata are pharmacologically safe, but the technology-based supercritical extract significantly reduces the absorption of metformin.
Supporting Evidence
- Both extracts did not show significant adverse reactions at tested doses.
- The traditional extract did not affect metformin pharmacokinetics.
- The supercritical extract significantly reduced metformin absorption.
- Cardiovascular parameters remained stable in treated rats.
- No mortality was observed during the study period.
- Safety pharmacology studies are essential for herbal medicines.
- Regulatory concerns necessitate evidence for safety of new extraction methods.
- Further studies are needed to explore the implications of herb-drug interactions.
Takeaway
This study looked at a plant called Cassia auriculata to see if it was safe and how it interacts with a diabetes medicine called metformin. It found that while the plant is safe, one way of making it can make the medicine work less well.
Methodology
Rats were fed with two types of Cassia auriculata extracts for 12 weeks, and their cardiovascular health and interactions with metformin were monitored.
Potential Biases
Potential bias in the selection of extracts and doses used.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Wistar albino rats, aged 6–8 weeks, weighing 150–220 g.
Statistical Information
P-Value
p<0.01 for significant findings.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website